Webinar on "Statistics for Quality Control and Process Validation: The Poisson Distribution and Non-parametric Tests"

Top Quote Data from testing and measuring usually follow mathematical distributions other than normal distribution, or what is called the Bell-Shaped curve. Among these, the Poisson Distribution, which describes low frequency events, occupies a prime place. End Quote
  • Fresno, CA (1888PressRelease) January 22, 2013 - Data from testing and measuring usually follow mathematical distributions other than normal distribution, or what is called the Bell-Shaped curve. Among these, the Poisson Distribution, which describes low frequency events, occupies a prime place.
    This webinar will describe the application of this distribution to results from microbial testing. A common challenge encountered by workers in this field is when they do not know what distribution equation describes the data that are being studied. The solution is to apply non-parametric methods, which come in handy in situations like this. This session will take this aspect up too, for discussion and describes these methods and their application.

    This session will cover the following areas:
    o The Poisson Distribution and two equations used in its application.
    o Application to microbial contamination testing.
    o The Spearman - Karber test for counting viruses.
    o The Wilcoxon signed Rank Test
    o Tukey's Quick test.

    When:January 22, 2013, 12:30 AM PDT | 03:30 PM EDT

    By whom:
    Steven S. Kuwahara, Ph.D., is the founder and Principal of GXP BioTechnology LLC, a consulting firm that works in the areas covered by the GLP and GMP of drugs, biologics, and nutraceuticals. After securing degrees in Biochemistry from Cornell and the University of Wisconsin, Steven started off as an Assistant Professor of Chemistry. His testing skills were honed in the initial years of his career at the Division of Biologic Products at the Michigan Department of Public Health (now BioPort Corp.), where he became the head of Quality Control. Here, he developed expertise in the testing of blood derivatives, viral and bacterial vaccines.

    His work has also dealt with all aspects of GMP and GLP in relation to biopharmaceuticals. He has worked with small molecules, proteins, cells, and gene therapy vectors.

    During an impressive career spanning over 30 years, Steven has applied his academic knowledge to quality control in the pharmaceutical industry. Steven has written several papers and book chapters, and serves on the editorial advisory boards of BioPharm, BioQuality, and the Journal of GXP Compliance. He has held certifications as a CQA, CQT, and CQE from the American Society of Quality and was certified (RAC) by the Regulatory Affairs Professionals Society.

    For whom:
    The webinar will benefit
    o Regulatory Affairs personnel who prepare the CMC sections of submissions
    o Development personnel who will set the early specifications
    o R & D personnel who will contribute data for use in development
    o Project managers for product development studies
    o Quality systems auditors
    o Consultants

    Duration: 90 minutes

    To enroll for this webinar, contact
    webinars ( @ ) globalcompliancepanelcom
    Phone: 800-447-9407

    ###
space
space
  • FB Icon Twitter Icon In-Icon
Contact Information